{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:35:31Z","timestamp":1793284531591,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Anti-amyloid monoclonal antibodies provide disease-modifying treatment options for selected patients with early symptomatic Alzheimer disease, but introduce new challenges for acute stroke care. Amyloid-related imaging abnormalities (ARIA) are often asymptomatic; however, symptomatic ARIA may cause aphasia, focal weakness, visual disturbance, confusion, headache, or seizures, and can resemble acute ischemic stroke. Initial noncontrast computed tomography may be nondiagnostic in both conditions, and failure to identify anti-amyloid exposure can complicate time-sensitive reperfusion decisions. Current regulatory guidance advises caution when considering thrombolytic therapy because serious and fatal intracerebral hemorrhage has been reported, although the absolute risk and a safe interval following anti-amyloid administration remain uncertain. Conversely, attributing every acute neurological deficit to ARIA could delay effective reperfusion for a true ischemic stroke. This editorial examines the clinical and imaging features relevant to this diagnostic overlap and proposes a systems-based response involving reliable medication identification, rapid vascular imaging, targeted magnetic resonance imaging, specialist collaboration, and separate consideration of intravenous thrombolysis and mechanical thrombectomy. Anti-amyloid exposure should be recognized as time-critical information during stroke evaluation. The objective is not automatic exclusion from reperfusion, but an individualized approach that minimizes avoidable hemorrhagic harm while preserving appropriate treatment for confirmed cerebral ischemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005585","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:01:24Z","timestamp":1787850084000},"page":"5550-5553","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Before the bolus: why anti-amyloid therapy must become part of every stroke code"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2128-1181","authenticated-orcid":false,"given":"Abdul S.","family":"Khaliq","sequence":"first","affiliation":[{"name":"Trauma and Emergency Department, Jinnah Hospital, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7747-2745","authenticated-orcid":false,"given":"Kaleem","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Balkh University, Mazar-i-Sharif, Balkh, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"R1-20261029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/jpm15090437","article-title":"Anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: evidence, ARIA risk, and precision patient selection","volume":"15","author":"Alkhalifa","year":"2025","journal-title":"J Pers Med"},{"key":"R2-20261029","doi-asserted-by":"crossref","first-page":"4414\u201324","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological, and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"R3-20261029","doi-asserted-by":"crossref","first-page":"9\u201321","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"R4-20261029","doi-asserted-by":"crossref","first-page":"512\u201327","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"R5-20261029","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/STR.0000000000000480","article-title":"Vascular neurology considerations for antiamyloid immunotherapy: a science advisory from the American Heart Association","volume":"56","author":"Greenberg","year":"2025","journal-title":"Stroke"},{"key":"R6-20261029","doi-asserted-by":"crossref","first-page":"1103\u201311","DOI":"10.1007\/s40266-025-01253-x","article-title":"Amyloid-related imaging abnormalities (ARIA) in the context of Alzheimer\u2019s disease and amyloid-targeting therapies: an introduction for advanced practice providers","volume":"42","author":"Schreiber","year":"2025","journal-title":"Drugs Aging"},{"key":"R7-20261029","doi-asserted-by":"crossref","first-page":"461\u201369","DOI":"10.1001\/jamaneurol.2025.0065","article-title":"Amyloid-related imaging abnormalities with donanemab in early symptomatic Alzheimer disease: secondary analysis of the TRAILBLAZER-ALZ and ALZ 2 randomized clinical trials","volume":"82","author":"Zimmer","year":"2025","journal-title":"JAMA Neurol"},{"key":"R8-20261029","doi-asserted-by":"crossref","first-page":"11094\u2013102","DOI":"10.21037\/qims-2025-1005","article-title":"Acute stroke diagnosis: diagnostic efficacy of dual-layer spectral computed tomography for non-contrast ischemic sign detection","volume":"15","author":"Wang","year":"2025","journal-title":"Quant Imaging Med Surg"},{"key":"R9-20261029","doi-asserted-by":"crossref","first-page":"360\u201366","DOI":"10.1590\/0100-3984.2020.0168","article-title":"Importance of computed tomography angiography in acute\/hyperacute ischemic stroke","volume":"54","author":"Dias","year":"2021","journal-title":"Radiol Bras"},{"key":"R10-20261029","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.tjpad.2025.100150","article-title":"Donanemab: appropriate use recommendations","volume":"12","author":"Rabinovici","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"R11-20261029","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/jcm13051245","article-title":"The impact of anti-amyloid immunotherapies on stroke care","volume":"13","author":"Bilodeau","year":"2024","journal-title":"J Clin Med"},{"key":"R12-20261029","doi-asserted-by":"crossref","first-page":"e71361","DOI":"10.1002\/alz.71361","article-title":"Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer\u2019s disease: an update from the Alzheimer\u2019s Association ARIA workgroup","volume":"22","author":"van Etten","year":"2026","journal-title":"Alzheimers Dement"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:03:13Z","timestamp":1793282593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005585","relation":{},"ISSN":["2049-0801","2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"},{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2026-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}